Sait Alan

Dr. Sait Alan

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2014 in Echocardiography
Verified
Journal Article
Closed access
PDF file
NPNihat Polat
Nihat Polat
AYAbdulkadir Yildiz
Abdulkadir Yildiz
MYMurat Yuksel
Murat Yuksel
HAHalit Acet
Halit Acet
SASait Alan
Sait Alan

8 May 2026 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
SASait Alan
Sait Alan
BABircan Alan
Bircan Alan
Aim: This study investigated coronary slow flow (CSF) prevalence in post-COVID-19 patients presenting with unstable angina (UA) and angiographically normal coronary arteries. Materials and methods: The study included 190 patients presenting with unstable angina (UA) and confirmed normal coronary arteries via invasive angiography. Participants were divided into two age- and sex-matched groups: 95 patients with a history of COVID-19 [COVID (+) UA-NCA] and 95 patients without a prior history of the infection [COVID (–) UA-NCA]. In the study group, COVID-19 was confirmed via RT-PCR and computed tomography. All participants underwent coronary angiography to perform Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC) measurements. CSF was diagnosed in patients with a corrected TFC (CTFC) ≥ 27. Results: CSF prevalence was significantly higher in the COVID (+) UA-NCA group than in the COVID (–) UA-NCA group (18.9% vs. 5.3%, p = 0.003). Individual CTFC values for the LAD, LCX, and RCA were also significantly higher in the COVID (+) UA-NCA group compared to the COVID (–) UA-NCA group (26.1 ± 4.3 vs. 22.4 ± 2.6 [ p = 0.01], 24.3 ± 4.5 vs. 21.7 ± 2.4 [ p < 0.001], and 24.3 ± 4.5 vs. 21.4 ± 2.5 [ p < 0.001], respectively). Conclusions: CSF prevalence is significantly higher in patients with a history of COVID-19, suggesting persistent microvascular impairment.

1 October 2013 in JACC
Verified
Journal Article
Closed access
AYAbdulkadir Yıldız
Abdulkadir Yıldız
OBOnder Bilge
Onder Bilge
MBMehmet Zihni Bilik
Mehmet Zihni Bilik
MAMehmet Ata Akil
Mehmet Ata Akil
MOMustafa Oylumlu
Mustafa Oylumlu
SASait Alan
Sait Alan

2 September 2016 in Journal of Clinical and Experimental Investigations
Verified
Journal Article
Open access
PDF file
MBMehmet Zihni Bilik
Mehmet Zihni Bilik
AKAli Fuad Kara
Ali Fuad Kara
BGBülent Göğebakan
Bülent Göğebakan
MAMehmet Ata Akıl
Mehmet Ata Akıl
FÖFerhat Özyurtlu
Ferhat Özyurtlu
SASait Alan
Sait Alan
Objectives: Coronary artery calcification (CAC) is associated with coronary atherosclerosis. There is a significant relation between coronary artery wall calcification and coronary artery disease (CAD). The measure of coronary artery calcification is an indicator of subclinical atherosclerosis. In some studies, it has been shown that coronary artery calcification is independent from conventional cardiovascular risks, which suggests data about prognosis. Matrix Gla protein (MGP) is an important protective modulator against calcification since it is an inhibitor of tissue calcification. In this respect, we aimed to establish the relationship between the distributions of nucleotide alterations found in promoter and coding regions of the MGP gene in patients with CAD and patients with normal coronary. Methods: DNA samples (n=115) were obtained from 58 patients with CAD and 57 healthy controls. The DNA samples obtained were analyzed by a Polymerase Chain Reaction (PCR) method using three sets of primer pairs, which cover the coding (Thr83Ala in exon 4) and promoter regions (T-138C and G-7A) of the MGP gene. Amplified regions were analyzed by a Restriction Fragment Length Polymorphism (RFLP) method for possible polymorphisms. Results: The chi-square analysis of the results revealed that there is no relationship between the observed polymorphisms and CAD. Conclusions: In this study, we investigated the relationship between MGP gene polymorphism and CAD. However, according to our findings, there was no statistically significant difference between the CAD and the control group.

1 October 2013 in JACC
Verified
Journal Article
Closed access
FEFaruk Ertas
Faruk Ertas
MOMustafa Oylumlu
Mustafa Oylumlu
MAMehmet Ata Akıl
Mehmet Ata Akıl
HAHalit Acet
Halit Acet
MBMehmet Zihni Bilik
Mehmet Zihni Bilik
HÖHakan Özhan
Hakan Özhan